Form 4: Tenet Healthcare Director Sells Shares

A Tenet Healthcare Corp. director sold 3,952 shares of common stock for $176.39 per share, reducing their beneficial ownership to 12,358 shares.

Summary

• Christopher S. Lynch, a Director of Tenet Healthcare Corp. (THC), sold 3,952 shares of common stock.
• The transaction occurred on August 19, 2025, at a price of $176.39 per share.
• Following this sale, Mr. Lynch beneficially owns 12,358 shares of Tenet Healthcare common stock.
• The transaction was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 4

Explanation: The sale by a director is a slight negative signal, but the fact that it was executed under a pre-arranged 10b5-1 plan mitigates concerns that it's based on new, negative information, making the overall sentiment neutral to slightly negative.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on new, undisclosed material information.

Negatives

• A director's sale of shares, even if pre-planned, reduces insider ownership and can be perceived as a slight negative signal by some investors.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports an individual insider transaction and does not provide broader context on industry trends or competitive landscape within the healthcare sector.

Stakeholder Impact

• Shareholders: May interpret the director's sale as a slight reduction in insider confidence, though the 10b5-1 plan suggests it's for personal financial planning rather than a bearish view on the company.

Key Dates

Keywords

Tenet Healthcare, THC, Insider Trading, Form 4, Director Sale, Stock Transaction, 10b5-1 Plan, Healthcare